These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 20667042
1. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury. Hashimoto S, Nakajima F, Kamada H, Kawamura K, Satake M, Tadokoro K, Okazaki H. Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042 [Abstract] [Full Text] [Related]
2. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors. Saw CL, Hannach B, Petrazsko T, Nickerson P. Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429 [Abstract] [Full Text] [Related]
3. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Reil A, Keller-Stanislawski B, Günay S, Bux J. Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261 [Abstract] [Full Text] [Related]
5. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007). Keller-Stanislawski B, Reil A, Günay S, Funk MB. Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122 [Abstract] [Full Text] [Related]
6. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience. Sachs UJ, Link E, Hofmann C, Wasel W, Bein G. Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817 [Abstract] [Full Text] [Related]
7. How much residual plasma may cause TRALI? Win N, Chapman CE, Bowles KM, Green A, Bradley S, Edmondson D, Wallis JP. Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733 [Abstract] [Full Text] [Related]
9. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines. Lucas G, Win N, Calvert A, Green A, Griffin E, Bendukidze N, Hopkins M, Browne T, Poles A, Chapman C, Massey E. Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747 [Abstract] [Full Text] [Related]
10. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations. Odent-Malaure H, Quainon F, Ruyer-Dumontier P, Ducroz S, Verdier P, Voitellier E, Raynal MF, Fromont P, Muller JY, Rebibo D, Absi L, Garraud O. Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109 [Abstract] [Full Text] [Related]
11. Transfusion-related acute lung injury (TRALI) in graft by blood donor antibodies against host leukocytes. Goodwin J, Tinckam K, denHollander N, Haroon A, Keshavjee S, Cserti-Gazdewich CM. J Heart Lung Transplant; 2010 Sep; 29(9):1067-70. PubMed ID: 20627626 [Abstract] [Full Text] [Related]
12. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine. Flesch BK, Petershofen EK, Bux J. Tissue Antigens; 2011 Jul; 78(1):1-7. PubMed ID: 21658007 [Abstract] [Full Text] [Related]
13. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Transfusion; 2004 Dec; 44(12):1683-8. PubMed ID: 15584980 [Abstract] [Full Text] [Related]
14. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Powers A, Stowell CP, Dzik WH, Saidman SL, Lee H, Makar RS. Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778 [Abstract] [Full Text] [Related]
15. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy. Vassallo RR, Hsu S, Einarson M, Barone J, Brodsky J, Moroff G. Transfusion; 2010 Aug; 50(8):1766-77. PubMed ID: 20345569 [Abstract] [Full Text] [Related]
16. HLA-DR antibodies in transfusion-related acute lung injury (TRALI): a case report. Muro M, Rivera J, Botella C, Campillo JA, Ferrer F, Alvarez-López MR. Transfus Apher Sci; 2008 Jun; 38(3):209-12. PubMed ID: 18462996 [Abstract] [Full Text] [Related]
17. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. ISBT Working Party on Granulocyte ImmunobiologyPlatelet and Leucocyte Immunology Laboratory, EFS Ile de France, Hopital Henri Mondor, Creteil, France., Bierling P, Bux J, Curtis B, Flesch B, Fung L, Lucas G, Macek M, Muniz-Diaz E, Porcelijn L, Reil A, Sachs U, Schuller R, Tsuno N, Uhrynowska M, Urbaniak S, Valentin N, Wikman A, Zupanska B. Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164 [Abstract] [Full Text] [Related]
18. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation. Nicolle AL, Chapman CE, Carter V, Wallis JP. Transfus Med; 2004 Jun; 14(3):225-30. PubMed ID: 15180814 [Abstract] [Full Text] [Related]
19. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury. Nishimura M, Hashimoto S, Takanashi M, Okazaki H, Satake M, Nakajima K. Transfus Med; 2007 Apr; 17(2):129-34. PubMed ID: 17430469 [Abstract] [Full Text] [Related]
20. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital. Nakagawa M, Toy P. Transfusion; 2004 Dec; 44(12):1689-94. PubMed ID: 15584981 [Abstract] [Full Text] [Related] Page: [Next] [New Search]